Javier Pascual

12PUBLICATIONS
102CO-AUTHORS
Predictive and prognostic markersMolecular targetsLiquid biopsiesCancer geneticsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 06, 2026
UGT2B17 as a predictive biomarker of complete pathological response in HER2 + breast cancer.

Ana Gil-Torralvo, M Ángeles Domínguez-Cejudo, Sonia Molina-Pinelo

|Oct 29, 2025
The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial.

Iseult M Browne, Javier Pascual, Rosalind J Cutts

|Jun 02, 2025
First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer.

François-Clément Bidard, Erica L Mayer, Yeon Hee Park

|May 15, 2024
Increased blood draws for ultrasensitive ctDNA and CTCs detection in early breast cancer patients.

Alfonso Alba-Bernal, Ana Godoy-Ortiz, María Emilia Domínguez-Recio

|Mar 21, 2024
Increasing Annual Cancer Incidence in Patients Age 20-49 Years: A Real-Data Study.

Nuria Ribelles, Javier Pascual, Laura Galvez-Carvajal

|Jul 25, 2023
Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients.

Javier Pascual, Miguel Gil-Gil, Paula Proszek

Pageof 2